Delphine Bregeon

Title: Delphine Bregeon: Innovator in Antibody Functionalization

Introduction

Delphine Bregeon is a prominent inventor based in Marseilles, France, known for her significant contributions to the field of immunology. With a total of eight patents to her name, she has made remarkable strides in the functionalization of antibodies, which are crucial for various therapeutic applications.

Latest Patents

Among her latest patents is the "Enzymatic conjugation of antibodies," which focuses on methods for the functionalization of immunoglobulins, particularly with drugs. This patent also discusses linking reagents, functionalized antibodies, pharmaceutical compositions, and methods for treating diseases and conditions. Another notable patent is the "Solid phase TGase-mediated conjugation of antibodies," which describes solid-support based processes for the functionalization of immunoglobulins using transglutaminase. This method can be applied in manufacturing processes or drug screening, showcasing her innovative approach to antibody development.

Career Highlights

Delphine has worked with esteemed organizations such as Innate Pharma and the Paul Scherrer Institut, where she has honed her skills and contributed to groundbreaking research in her field. Her work has not only advanced scientific understanding but has also paved the way for new therapeutic strategies.

Collaborations

Throughout her career, Delphine has collaborated with notable professionals, including Patrick Dennler and Laurent Gauthier. These partnerships have enriched her research and expanded the impact of her innovations.

Conclusion

Delphine Bregeon stands out as a leading inventor in the realm of antibody functionalization. Her patents and collaborations reflect her dedication to advancing medical science and improving treatment options for various diseases.